Inventiva S.A. (IVA)
NASDAQ·Healthcare·Biotechnology
$4.28
-4.46%
Mkt Cap $331.65M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$16.50
Range $12.00 – $24.00
Implied Upside
+285.5%
Consensus $16.50 vs current $4.28
NASDAQ·Healthcare·Biotechnology
$4.28
-4.46%
Mkt Cap $331.65M
No recent rating data.
Price Target (7 analysts)
$16.50
Range $12.00 – $24.00
+285.5%
Consensus $16.50 vs current $4.28